Advanced Biomed Inc. (ADVB) income statement
ADVBNasdaqServices-Medical LaboratoriesFiscal year ends June 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$2.15+0.05 (+2.62%)
Close on Nov 18, 2026Market cap $3.56MP/E 0.4Yield –
Advanced Biomed Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY2026
- Gross margin
- –
- Operating margin
- -4883.8%
- Net margin
- 5231.3%
- Return on equity, FY2026
- 84.8%
Financial strength
- Current ratio
- 9.33
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 26.2%
Valuation
- P/E ratio
- 0.4
- Price to sales
- –
- Price to book
- 0.29
- Dividend yield
- –
See a number that looks wrong?